$75,000 per year and $150,000 total, inclusive of both direct and indirect costs for the two-year project. - May 18, 2026 (LOI); September 8, 2026 (Invited Full Proposal)
Tuberous Sclerosis AllianceThis program supports innovative research on tuberous sclerosis complex (TSC) and epilepsy, focusing on phenotypic variability, signaling pathways, disease models, biomarkers, and new technologies, while addressing key needs.
